[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Blood Plasma Derivatives Sales Market Report 2017

February 2017 | 124 pages | ID: G752B3060CFEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Blood Plasma Derivatives

Revenue, means the sales value of Blood Plasma Derivatives

This report studies sales (consumption) of Blood Plasma Derivatives in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • SK Plasma (Korea)
  • Seraplex Inc.
  • Grifols (Germany)
  • CSL Limited (Australia)
  • Fusion Healthcare (India)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Blood Plasma Derivatives in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Fresh Frozen Plasma (FFP)
  • Intravenous immunoglobulin (IVIG)
  • Albumin
  • Factor VIII
  • Factor IX
Split by applications, this report focuses on sales, market share and growth rate of Blood Plasma Derivatives in each application, can be divided into
  • Hemophilia A
  • Hemophilia B
  • Others
Global Blood Plasma Derivatives Sales Market Report 2017

1 BLOOD PLASMA DERIVATIVES OVERVIEW

1.1 Product Overview and Scope of Blood Plasma Derivatives
1.2 Classification of Blood Plasma Derivatives
  1.2.1 Fresh Frozen Plasma (FFP)
  1.2.2 Intravenous immunoglobulin (IVIG)
  1.2.3 Albumin
  1.2.4 Factor VIII
  1.2.5 Factor IX
1.3 Application of Blood Plasma Derivatives
  1.3.1 Hemophilia A
  1.3.2 Hemophilia B
  1.3.3 Others
1.4 Blood Plasma Derivatives Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Blood Plasma Derivatives (2012-2022)
  1.5.1 Global Blood Plasma Derivatives Sales and Growth Rate (2012-2022)
  1.5.2 Global Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)

2 GLOBAL BLOOD PLASMA DERIVATIVES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Blood Plasma Derivatives Market Competition by Manufacturers
  2.1.1 Global Blood Plasma Derivatives Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Blood Plasma Derivatives Revenue and Share by Manufacturers (2012-2017)
2.2 Global Blood Plasma Derivatives (Volume and Value) by Type
  2.2.1 Global Blood Plasma Derivatives Sales and Market Share by Type (2012-2017)
  2.2.2 Global Blood Plasma Derivatives Revenue and Market Share by Type (2012-2017)
2.3 Global Blood Plasma Derivatives (Volume and Value) by Regions
  2.3.1 Global Blood Plasma Derivatives Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Blood Plasma Derivatives Revenue and Market Share by Regions (2012-2017)
2.4 Global Blood Plasma Derivatives (Volume) by Application

3 UNITED STATES BLOOD PLASMA DERIVATIVES (VOLUME, VALUE AND SALES PRICE)

3.1 United States Blood Plasma Derivatives Sales and Value (2012-2017)
  3.1.1 United States Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
  3.1.2 United States Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
  3.1.3 United States Blood Plasma Derivatives Sales Price Trend (2012-2017)
3.2 United States Blood Plasma Derivatives Sales and Market Share by Manufacturers
3.3 United States Blood Plasma Derivatives Sales and Market Share by Type
3.4 United States Blood Plasma Derivatives Sales and Market Share by Application

4 CHINA BLOOD PLASMA DERIVATIVES (VOLUME, VALUE AND SALES PRICE)

4.1 China Blood Plasma Derivatives Sales and Value (2012-2017)
  4.1.1 China Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
  4.1.2 China Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
  4.1.3 China Blood Plasma Derivatives Sales Price Trend (2012-2017)
4.2 China Blood Plasma Derivatives Sales and Market Share by Manufacturers
4.3 China Blood Plasma Derivatives Sales and Market Share by Type
4.4 China Blood Plasma Derivatives Sales and Market Share by Application

5 EUROPE BLOOD PLASMA DERIVATIVES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Blood Plasma Derivatives Sales and Value (2012-2017)
  5.1.1 Europe Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
  5.1.2 Europe Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Blood Plasma Derivatives Sales Price Trend (2012-2017)
5.2 Europe Blood Plasma Derivatives Sales and Market Share by Manufacturers
5.3 Europe Blood Plasma Derivatives Sales and Market Share by Type
5.4 Europe Blood Plasma Derivatives Sales and Market Share by Application

6 JAPAN BLOOD PLASMA DERIVATIVES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Blood Plasma Derivatives Sales and Value (2012-2017)
  6.1.1 Japan Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
  6.1.2 Japan Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Blood Plasma Derivatives Sales Price Trend (2012-2017)
6.2 Japan Blood Plasma Derivatives Sales and Market Share by Manufacturers
6.3 Japan Blood Plasma Derivatives Sales and Market Share by Type
6.4 Japan Blood Plasma Derivatives Sales and Market Share by Application

7 SOUTHEAST ASIA BLOOD PLASMA DERIVATIVES (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Blood Plasma Derivatives Sales and Value (2012-2017)
  7.1.1 Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Blood Plasma Derivatives Sales Price Trend (2012-2017)
7.2 Southeast Asia Blood Plasma Derivatives Sales and Market Share by Manufacturers
7.3 Southeast Asia Blood Plasma Derivatives Sales and Market Share by Type
7.4 Southeast Asia Blood Plasma Derivatives Sales and Market Share by Application

8 INDIA BLOOD PLASMA DERIVATIVES (VOLUME, VALUE AND SALES PRICE)

8.1 India Blood Plasma Derivatives Sales and Value (2012-2017)
  8.1.1 India Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
  8.1.2 India Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
  8.1.3 India Blood Plasma Derivatives Sales Price Trend (2012-2017)
8.2 India Blood Plasma Derivatives Sales and Market Share by Manufacturers
8.3 India Blood Plasma Derivatives Sales and Market Share by Type
8.4 India Blood Plasma Derivatives Sales and Market Share by Application

9 GLOBAL BLOOD PLASMA DERIVATIVES MANUFACTURERS ANALYSIS

9.1 SK Plasma (Korea)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Blood Plasma Derivatives Product Type, Application and Specification
    9.1.2.1 Fresh Frozen Plasma (FFP)
    9.1.2.2 Intravenous immunoglobulin (IVIG)
  9.1.3 SK Plasma (Korea) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Seraplex Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Blood Plasma Derivatives Product Type, Application and Specification
    9.2.2.1 Fresh Frozen Plasma (FFP)
    9.2.2.2 Intravenous immunoglobulin (IVIG)
  9.2.3 Seraplex Inc. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Grifols (Germany)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Blood Plasma Derivatives Product Type, Application and Specification
    9.3.2.1 Fresh Frozen Plasma (FFP)
    9.3.2.2 Intravenous immunoglobulin (IVIG)
  9.3.3 Grifols (Germany) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 CSL Limited (Australia)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Blood Plasma Derivatives Product Type, Application and Specification
    9.4.2.1 Fresh Frozen Plasma (FFP)
    9.4.2.2 Intravenous immunoglobulin (IVIG)
  9.4.3 CSL Limited (Australia) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Fusion Healthcare (India)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Blood Plasma Derivatives Product Type, Application and Specification
    9.5.2.1 Fresh Frozen Plasma (FFP)
    9.5.2.2 Intravenous immunoglobulin (IVIG)
  9.5.3 Fusion Healthcare (India) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview

10 BLOOD PLASMA DERIVATIVES MAUFACTURING COST ANALYSIS

10.1 Blood Plasma Derivatives Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Blood Plasma Derivatives
10.3 Manufacturing Process Analysis of Blood Plasma Derivatives

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Blood Plasma Derivatives Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Blood Plasma Derivatives Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BLOOD PLASMA DERIVATIVES MARKET FORECAST (2017-2022)

14.1 Global Blood Plasma Derivatives Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Blood Plasma Derivatives Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Blood Plasma Derivatives Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Blood Plasma Derivatives Price and Trend Forecast (2017-2022)
14.2 Global Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Blood Plasma Derivatives Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Blood Plasma Derivatives Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Blood Plasma Derivatives Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Blood Plasma Derivatives
Table Classification of Blood Plasma Derivatives
Figure Global Sales Market Share of Blood Plasma Derivatives by Type in 2015
Figure Fresh Frozen Plasma (FFP) Picture
Figure Intravenous immunoglobulin (IVIG) Picture
Figure Albumin Picture
Figure Factor VIII Picture
Figure Factor IX Picture
Table Applications of Blood Plasma Derivatives
Figure Global Sales Market Share of Blood Plasma Derivatives by Application in 2015
Figure Hemophilia A Examples
Figure Hemophilia B Examples
Figure Others Examples
Figure United States Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Figure China Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Figure Europe Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Figure Japan Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Figure India Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Figure Global Blood Plasma Derivatives Sales and Growth Rate (2012-2022)
Figure Global Blood Plasma Derivatives Revenue and Growth Rate (2012-2022)
Table Global Blood Plasma Derivatives Sales of Key Manufacturers (2012-2017)
Table Global Blood Plasma Derivatives Sales Share by Manufacturers (2012-2017)
Figure 2015 Blood Plasma Derivatives Sales Share by Manufacturers
Figure 2016 Blood Plasma Derivatives Sales Share by Manufacturers
Table Global Blood Plasma Derivatives Revenue by Manufacturers (2012-2017)
Table Global Blood Plasma Derivatives Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Blood Plasma Derivatives Revenue Share by Manufacturers
Table 2016 Global Blood Plasma Derivatives Revenue Share by Manufacturers
Table Global Blood Plasma Derivatives Sales and Market Share by Type (2012-2017)
Table Global Blood Plasma Derivatives Sales Share by Type (2012-2017)
Figure Sales Market Share of Blood Plasma Derivatives by Type (2012-2017)
Figure Global Blood Plasma Derivatives Sales Growth Rate by Type (2012-2017)
Table Global Blood Plasma Derivatives Revenue and Market Share by Type (2012-2017)
Table Global Blood Plasma Derivatives Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Blood Plasma Derivatives by Type (2012-2017)
Figure Global Blood Plasma Derivatives Revenue Growth Rate by Type (2012-2017)
Table Global Blood Plasma Derivatives Sales and Market Share by Regions (2012-2017)
Table Global Blood Plasma Derivatives Sales Share by Regions (2012-2017)
Figure Sales Market Share of Blood Plasma Derivatives by Regions (2012-2017)
Figure Global Blood Plasma Derivatives Sales Growth Rate by Regions (2012-2017)
Table Global Blood Plasma Derivatives Revenue and Market Share by Regions (2012-2017)
Table Global Blood Plasma Derivatives Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Blood Plasma Derivatives by Regions (2012-2017)
Figure Global Blood Plasma Derivatives Revenue Growth Rate by Regions (2012-2017)
Table Global Blood Plasma Derivatives Sales and Market Share by Application (2012-2017)
Table Global Blood Plasma Derivatives Sales Share by Application (2012-2017)
Figure Sales Market Share of Blood Plasma Derivatives by Application (2012-2017)
Figure Global Blood Plasma Derivatives Sales Growth Rate by Application (2012-2017)
Figure United States Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
Figure United States Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
Figure United States Blood Plasma Derivatives Sales Price Trend (2012-2017)
Table United States Blood Plasma Derivatives Sales by Manufacturers (2012-2017)
Table United States Blood Plasma Derivatives Market Share by Manufacturers (2012-2017)
Table United States Blood Plasma Derivatives Sales by Type (2012-2017)
Table United States Blood Plasma Derivatives Market Share by Type (2012-2017)
Table United States Blood Plasma Derivatives Sales by Application (2012-2017)
Table United States Blood Plasma Derivatives Market Share by Application (2012-2017)
Figure China Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
Figure China Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
Figure China Blood Plasma Derivatives Sales Price Trend (2012-2017)
Table China Blood Plasma Derivatives Sales by Manufacturers (2012-2017)
Table China Blood Plasma Derivatives Market Share by Manufacturers (2012-2017)
Table China Blood Plasma Derivatives Sales by Type (2012-2017)
Table China Blood Plasma Derivatives Market Share by Type (2012-2017)
Table China Blood Plasma Derivatives Sales by Application (2012-2017)
Table China Blood Plasma Derivatives Market Share by Application (2012-2017)
Figure Europe Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
Figure Europe Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
Figure Europe Blood Plasma Derivatives Sales Price Trend (2012-2017)
Table Europe Blood Plasma Derivatives Sales by Manufacturers (2012-2017)
Table Europe Blood Plasma Derivatives Market Share by Manufacturers (2012-2017)
Table Europe Blood Plasma Derivatives Sales by Type (2012-2017)
Table Europe Blood Plasma Derivatives Market Share by Type (2012-2017)
Table Europe Blood Plasma Derivatives Sales by Application (2012-2017)
Table Europe Blood Plasma Derivatives Market Share by Application (2012-2017)
Figure Japan Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
Figure Japan Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
Figure Japan Blood Plasma Derivatives Sales Price Trend (2012-2017)
Table Japan Blood Plasma Derivatives Sales by Manufacturers (2012-2017)
Table Japan Blood Plasma Derivatives Market Share by Manufacturers (2012-2017)
Table Japan Blood Plasma Derivatives Sales by Type (2012-2017)
Table Japan Blood Plasma Derivatives Market Share by Type (2012-2017)
Table Japan Blood Plasma Derivatives Sales by Application (2012-2017)
Table Japan Blood Plasma Derivatives Market Share by Application (2012-2017)
Figure Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
Figure Southeast Asia Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Blood Plasma Derivatives Sales Price Trend (2012-2017)
Table Southeast Asia Blood Plasma Derivatives Sales by Manufacturers (2012-2017)
Table Southeast Asia Blood Plasma Derivatives Market Share by Manufacturers (2012-2017)
Table Southeast Asia Blood Plasma Derivatives Sales by Type (2012-2017)
Table Southeast Asia Blood Plasma Derivatives Market Share by Type (2012-2017)
Table Southeast Asia Blood Plasma Derivatives Sales by Application (2012-2017)
Table Southeast Asia Blood Plasma Derivatives Market Share by Application (2012-2017)
Figure India Blood Plasma Derivatives Sales and Growth Rate (2012-2017)
Figure India Blood Plasma Derivatives Revenue and Growth Rate (2012-2017)
Figure India Blood Plasma Derivatives Sales Price Trend (2012-2017)
Table India Blood Plasma Derivatives Sales by Manufacturers (2012-2017)
Table India Blood Plasma Derivatives Market Share by Manufacturers (2012-2017)
Table India Blood Plasma Derivatives Sales by Type (2012-2017)
Table India Blood Plasma Derivatives Market Share by Type (2012-2017)
Table India Blood Plasma Derivatives Sales by Application (2012-2017)
Table India Blood Plasma Derivatives Market Share by Application (2012-2017)
Table SK Plasma (Korea) Basic Information List
Table SK Plasma (Korea) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SK Plasma (Korea) Blood Plasma Derivatives Global Market Share (2012-2017)
Table Seraplex Inc. Basic Information List
Table Seraplex Inc. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Seraplex Inc. Blood Plasma Derivatives Global Market Share (2012-2017)
Table Grifols (Germany) Basic Information List
Table Grifols (Germany) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Grifols (Germany) Blood Plasma Derivatives Global Market Share (2012-2017)
Table CSL Limited (Australia) Basic Information List
Table CSL Limited (Australia) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited (Australia) Blood Plasma Derivatives Global Market Share (2012-2017)
Table Fusion Healthcare (India) Basic Information List
Table Fusion Healthcare (India) Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Fusion Healthcare (India) Blood Plasma Derivatives Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Blood Plasma Derivatives
Figure Manufacturing Process Analysis of Blood Plasma Derivatives
Figure Blood Plasma Derivatives Industrial Chain Analysis
Table Raw Materials Sources of Blood Plasma Derivatives Major Manufacturers in 2015
Table Major Buyers of Blood Plasma Derivatives
Table Distributors/Traders List
Figure Global Blood Plasma Derivatives Sales and Growth Rate Forecast (2017-2022)
Figure Global Blood Plasma Derivatives Revenue and Growth Rate Forecast (2017-2022)
Table Global Blood Plasma Derivatives Sales Forecast by Regions (2017-2022)
Table Global Blood Plasma Derivatives Sales Forecast by Type (2017-2022)
Table Global Blood Plasma Derivatives Sales Forecast by Application (2017-2022)


More Publications